INDIVIOR PLC (INVVY)

5.20
OTC Markets
Prev Close 5.29
Day Low/High 5.20 / 5.36
52 Wk Low/High 5.20 / 33.83
Exchange OTC Markets
Shares Outstanding 728.44B
Market Cap 770.69M
Div & Yield N.A. (N.A)

Latest News

Court Of Appeals For The Federal Circuit Lifts Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film

Court Of Appeals For The Federal Circuit Lifts Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film

-Company will continue to defend its intellectual property and implement contingency plan­

PERSERIS™, The First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available In The U.S. For The Treatment Of Schizophrenia In Adults

PERSERIS™, The First Once-Monthly Risperidone-Containing Subcutaneous Long-Acting Injectable, Now Available In The U.S. For The Treatment Of Schizophrenia In Adults

PERSERIS delivers risperidone in a new once-monthly extended-release delivery system. Neither a loading dose nor any supplemental oral risperidone is recommended.

Indivior Announces Upcoming Investor Events

Indivior Announces Upcoming Investor Events

SLOUGH, United Kingdom and RICHMOND, Va., Nov.

Indivior Announces Nine Month And Third Quarter 2018 Results

Indivior Announces Nine Month And Third Quarter 2018 Results

SLOUGH, United Kingdom and RICHMOND, Va., Nov.

Indivior Applauds Enactment Of The SUPPORT For Patients And Communities Act Of 2018

Indivior Applauds Enactment Of The SUPPORT For Patients And Communities Act Of 2018

Act Broadens Access to Medication-Assisted Treatment for People Affected by Opioid Addiction

Indivior Provides Update On Key Business Drivers And Expectations

Indivior Provides Update On Key Business Drivers And Expectations

This announcement contains inside information.

Indivior Unable To Participate In Morgan Stanley Healthcare Conference Due To Adverse Weather

Indivior Unable To Participate In Morgan Stanley Healthcare Conference Due To Adverse Weather

SLOUGH, England and RICHMOND, Va., Sept.

Indivior Prepays $150 Million Of Outstanding Debt

Indivior Prepays $150 Million Of Outstanding Debt

SLOUGH, England and RICHMOND, Va., Sept.

DURECT Announces Receipt Of $5 Million Milestone Payment From Indivior

DURECT Announces Receipt Of $5 Million Milestone Payment From Indivior

Milestone payment triggered by NDA approval of PERSERIS™ (risperidone)

Indivior Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film Upheld

Indivior Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film Upheld

- Company will continue to vigorously defend our SUBOXONE® (buprenorphine and naloxone) Sublingual Film intellectual property -

DURECT Announces FDA Approval Of Indivior's PERSERIS™ (risperidone) Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults

DURECT Announces FDA Approval Of Indivior's PERSERIS™ (risperidone) Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults

Approval triggers $5 million milestone payment to DURECT and future earn-out payments based on U.S. net sales

FDA Approves PERSERIS™ (risperidone) For Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults

FDA Approves PERSERIS™ (risperidone) For Extended-Release Injectable Suspension For The Treatment Of Schizophrenia In Adults

PERSERIS is the first once-monthly subcutaneous risperidone-containing long-acting injectable

Indivior Is Granted Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film

Indivior Is Granted Preliminary Injunction On Generic (buprenorphine And Naloxone) Sublingual Film

SLOUGH, England , July 13, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.

Indivior Sees FY 2018 Net Revenue And Adjusted Net Income Below Previous Expectations

Indivior Sees FY 2018 Net Revenue And Adjusted Net Income Below Previous Expectations

SLOUGH, England, July 11, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that its previous FY 2018 financial guidance (net revenue: $1,130m - $1,170m; adjusted net income: $280m - $320m) is no longer valid...

Indivior To Announce And Present Half Year 2018 Results On July 25th

Indivior To Announce And Present Half Year 2018 Results On July 25th

SLOUGH, England and RICHMOND, Va., July 10, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that it will release its half year 2018 results on July 25 th at 7:00 a.

Indivior's Temporary Restraining Order Is Extended

Indivior's Temporary Restraining Order Is Extended

SLOUGH, England, June 28, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.

Indivior Is Granted Temporary Restraining Order

Indivior Is Granted Temporary Restraining Order

SLOUGH, England, June 15, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.

Indivior Responds To Generic SUBOXONE® Approvals And Dr. Reddy's Launch "At-Risk"

Indivior Responds To Generic SUBOXONE® Approvals And Dr. Reddy's Launch "At-Risk"

SLOUGH, England, June 15, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that it is aware that, on 14 June 2018, the US FDA approved generic versions of SUBOXONE® Film from both Dr.

The 6 Medications Being Used to Tackle the Opioid Epidemic

The 6 Medications Being Used to Tackle the Opioid Epidemic

The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.

Indivior Shares Plunge Amid Generics Threat to Suboxone Opioid Treatment

Indivior Shares Plunge Amid Generics Threat to Suboxone Opioid Treatment

The FTSE 250 pharmaceutical company said the U.S. District Court in Delaware has found that claims of a proposed generic version of Indivior's opioid addiction treatment by Dr. Reddy's does not infringe patents.

European Stock Markets Fall on Growth Worries, Oil Price Declines

European Stock Markets Fall on Growth Worries, Oil Price Declines

Société Générale, Deutsche Bank among biggest losers.

States Accuse Heroin Addiction Treatment Maker Indivior of Blocking Generics

States Accuse Heroin Addiction Treatment Maker Indivior of Blocking Generics

Indivior shares drop 16% in London on news of the lawsuit.

European Markets Down Ahead of Fed Minutes

European Markets Down Ahead of Fed Minutes

Semiconductor industry player ASML falls on reported snub from Intel.

European Markets Open Mostly Down; ASML Falls on Intel Snub

European Markets Open Mostly Down; ASML Falls on Intel Snub

U.S. futures point to markets opening in the red.